Job, patent and robot

> While recent advances in nanotech hold promise for targeted drug delivery, there is still work to be done in making sure all nanoparticles reach tumors in a uniform way. It's a problem that needs to be overcome if nano-enabled drug delivery is to reach its full potential. Massachusetts researchers discuss how to overcome these barriers. Abstract

Drug delivery job of the week: Vice president, project management, Ekteino Laboratories, Boston—a startup, drug delivery-based research company that is working with a unique technology licensed from a leading university. Job listing

> Drug delivery patent application of the week: Delivery of Oligonucleotide-Functionalized Nanoparticles. More

> Drug delivery robot of the week: MKR-003 Robot

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.